Deprescribing and Polypharmacy in an Aging Population

Dr. Elbeddini is Affiliate Investigator in Epidemiology at Ottawa Hospital Research Institute (OHRI), Canada. He previously an Assistant Professor in Clinical Pharmacy at Skaggs School of Pharmacy, University of Colorado, USA and conducted post-doctorate research at Harvard Medical School (HMS) in Global Clinical Scholars Research Education program.

1. A global overview of the current state of deprescribing 2. Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation 3. Deprescribing is an essential part of prescribing 4. Deprescribing in school curriculums: An overview of current education standards and what should be changed 5. The role of the multidisciplinary healthcare team in deprescribing 6. Looking to the future: Artificial intelligence in enhancing patient care 7. Challenges/barriers of deprescribing during Covid-19 8. Deprescribing in pallative care and Alzheimer's patients: Optimizing medication use for improved quality of life